Neurodegenerative disease

There are 3,529 papers on neurodegenerative disease in aging research: 21 trials and 474 observational studies in people, 482 in animals, 25 in cells, 2,414 reviews. The newest story, Nov 17, 2026: “Portable brain scans agree best on larger brain structures”.

Disease

3,529 papers study it4,334 more mention it820 findings

MeSH

198 new papers in 30 daysSee all 7,863 papers on neurodegenerative disease

“those with more severe baseline neurodegeneration had greater improvement in segregation after training”
Increased segregation of structural brain networks underpins enhanced broad cognitive abilities of cognitive trainingHuman brain mapping2021doi:10.1002/hbm.25428
  • Human trial21
  • Humans474
  • Animals328
  • Model organisms154
  • Cells25
  • In silico90

Interventions

112

Exercise

downin reviews9downin humans2upin rats1downin worms1

13 studies
  1. Exercise decreases neurodegenerative disease (mediated by exerkines acting on the NLRP3 inflammasome).

    “precisely target the excessive activation of the NLRP3 inflammasome and thereby ameliorate neurodegeneration”

    Reviewmediated by exerkines acting on the NLRP3 inflammasome

    Exerkine-Mediated Regulation of the NLRP3 Inflammasome in Neuroprotection: Mechanistic Insights and the Role of Exercise

    Molecular neurobiology

  2. Exercise protects against neurodegenerative disease.

    “Polyphenols and regular physical activity are increasingly recognized as complementary lifestyle interventions that influence the gut-brain axis and contribute to neuroprotection.”

    Review

    Polyphenols and physical activity stimulate gut microbiota mediated Nrf2 signaling to combat neurodegeneration

    Pathology, research and practice

  3. Exercise prevents neurodegenerative disease in humans.

    “also prevents neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and dementias”

    Review

    Exercise: a superhero for your brain

    Con Evidencia

  4. Exercise protects against neurodegenerative disease.

    “physical exercise plays an important role in promoting brain health, supporting neuroplasticity and potentially serving as a preventive or complementary strategy to delay the development of neurodegenerative diseases”

    Review

    Effects of physical exercise on neuroplasticity and the prevention of neurodegenerative diseases: an integrative review

    Brazilian Journal of Implantology and Health Sciences

  5. Exercise prevents neurodegenerative disease in humans (review of evidence).

    “exercise, as a non-pharmacological intervention, can prevent and manage obesity, diabetes, and neurodegenerative diseases”

    Reviewreview of evidence

    Gut microbiota: new links between exercise and disease

    Frontiers in microbiology

  6. Exercise protects against neurodegenerative disease.

    “approaches to trigger mitohormesis, such as physical exercise, have beneficial effects in neurodegenerative disorders.”

    Review

    What Are the Roles of Mitochondrial Stress Responses and Mitohormesis in Neurodegenerative Disorders?

    Neurology

  7. Exercise protects against neurodegenerative disease.

    “physical activity has been identified as a potent intervention that enhances neuroplasticity and metabolic resilience while mitigating the effects of neurodegeneration”

    Review

    The interplay between physical exercise and autophagy signaling in brain health, neurodegenerative diseases and aging

    Frontiers in aging neuroscience

  8. Exercise protects against neurodegenerative disease in neurodegenerative disease models.

    “limit risk and/or provide neuroprotection in neurodegenerative disease models”

    Reviewin neurodegenerative disease models

    Amino acid neurotransmitters in sarcopenia and healthy aging

    Brain research bulletin

  9. Exercise protects against neurodegenerative disease.

    “exercise as a pleiotropic intervention that transcends single-organ influences, instead leveraging multi-tissue networks to delay aging and neurodegeneration”

    Review

    Exercise orchestrates systemic metabolic and neuroimmune homeostasis via the brain-muscle-liver axis to slow down aging and neurodegeneration: a narrative review

    European journal of medical research

  10. Exercise induces neurodegenerative disease in rats (physical overexertion).

    “These changes demonstrate that neurodegeneration in the cerebellum takes place in response to physical overexertion.”

    Animalsphysical overexertioncerebellar cortex

    Changes in the Cyto- and Fibroarchitectonics of the Cerebellar Cortex in Rats Subjected to Extreme Physical Activity

    Biology

All 13

More on Exercise

Caloric restriction

downin reviews4downin mice2downin rodent1

7 studies
  1. Caloric restriction protects against neurodegenerative disease.

    “Although caloric restriction (CR) has consistently demonstrated neuroprotective effects”

    Review

    Nanodelivery strategies for caloric restriction mimetics in age-associated neurodegeneration

    Ageing research reviews

  2. Caloric restriction protects against neurodegenerative disease.

    “Metabolic interventions like caloric restriction, intermittent fasting, and ketogenic diets have demonstrated neuroprotective effects”

    Review

    Harnessing Metabolism to Combat Neurodegeneration: Strategies for Reversing Age-Related Cognitive Decline

    ACS pharmacology & translational science

  3. Caloric restriction decreases neurodegenerative disease in mice (chronic and intermittent calorie restriction versus ad libitum).

    “Image quantification demonstrated significant neurodegeneration in the AL group compared to the CCR and ICR group”

    Animalschronic and intermittent calorie restriction versus ad libitumhippocampus

    Neurodegeneration: Effects of calorie restriction on the brain sirtuin protein levels

    Behavioural brain research

  4. Caloric restriction protects against neurodegenerative disease in murine models of age-related disorders.

    “intermittent fasting and caloric restriction (CR) can counteract disease processes in various age-related disorders, including NDs”

    Reviewin murine models of age-related disorders

    Perspective: The Impact of Fasting and Caloric Restriction on Neurodegenerative Diseases in Humans

    Advances in nutrition (Bethesda, Md.)

  5. Caloric restriction inhibits neurodegenerative disease.

    “retarding effect on the progression of neurodegenerative diseases”

    Review

    Beneficial Effects on Brain Micro-Environment by Caloric Restriction in Alleviating Neurodegenerative Diseases and Brain Aging

    Frontiers in physiology

  6. Caloric restriction prevents neurodegenerative disease in rodent (overnight restriction before asphyxial cardiac arrest) (complete prevention).

    “complete prevention of neurodegeneration in multiple regions of the brain”

    Animalsovernight restriction before asphyxial cardiac arrestovernightbrain75% over 14 h14 h

    Overnight Caloric Restriction Prior to Cardiac Arrest and Resuscitation Leads to Improved Survival and Neurological Outcome in a Rodent Model

    Frontiers in neuroscience

  7. Caloric restriction protects against neurodegenerative disease.

    “caloric restriction and physical activity, which may counteract ageing and associated neurodegenerative diseases”

    Review

    Dietary habits, lifestyle factors and neurodegenerative diseases

    Neural regeneration research

More on Caloric restriction

Metformin

downin reviews2downin A. models1no changein humans1downin rats1+1

6 studies
  1. Metformin was not clearly linked with neurodegenerative disease in humans (first 2 years of exposure vs no metformin use).

    “while metformin exposure in the first 2 years showed no significant influence”

    Humansfirst 2 years of exposure vs no metformin usefirst 2 yearspredominantly male (98%)s

    Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus

    BMJ open

  2. Metformin protects against neurodegenerative disease in preclinical disease models.

    “consistently demonstrate neuroprotective and neuromodulatory effects of metformin in models of Alzheimer's disease, Parkinson's disease, stroke, and fragile X syndrome”

    Reviewin preclinical disease modelscentral nervous system

    Exploring the impact of metformin on the central nervous system and neurotransmission: A systematic review

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  3. Metformin protects against neurodegenerative disease in Rodentia (trimethyltin-induced model).

    “prevented the loss of CA1 pyramidal neurons”

    Animalstrimethyltin-induced modelhippocampus200 mg/kg daily3 weeks

    Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration

    Cellular and molecular neurobiology

  4. Metformin protects against neurodegenerative disease.

    “Experimental data on animal models shows promising results, but clinical studies are inconclusive.”

    Review

    Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders

    Pharmaceuticals (Basel, Switzerland)

  5. Metformin protects against neurodegenerative disease (hormesis-induced protective responses).

    “delays the onset and slows the progression of neurodegenerative and other chronic diseases”

    Reviewhormesis-induced protective responses

    Metformin-enhances resilience via hormesis

    Ageing research reviews

  6. Metformin decreases neurodegenerative disease in rats (D-galactose mimetic aging model).

    “the regulation of the UPR and AMPK/ERK1/2 signaling pathway by metformin significantly attenuated hearing loss, cell apoptosis and age‐related neurodegeneration”

    AnimalsD-galactose mimetic aging model

    Metformin attenuates the D‑galactose‑induced aging process via the UPR through the AMPK/ERK1/2 signaling pathways

    International journal of molecular medicine

More on Metformin

Ergothioneine

downin reviews4

4 studies
  1. Ergothioneine prevents neurodegenerative disease (Reviewed cellular, animal, epidemiologic, and human intervention evidence).

    “Evidence that ET prevents and inhibits the development of neurodegenerative diseases, especially Alzheimer’s disease and Parkinson’s disease, has been accumulated”

    ReviewReviewed cellular, animal, epidemiologic, and human intervention evidence

    Ergothioneine: A Natural Antioxidant Claimed to Prevent Neurodegeneration

    Nutrients

  2. Ergothioneine protects against neurodegenerative disease.

    “protecting against age-related diseases, especially neurodegenerative diseases”

    Review

    Ergothioneine as an emerging food-derived bioactive compound protecting against age-related diseases: issues needing more research

    The American journal of clinical nutrition

  3. Ergothioneine prevents neurodegenerative disease.

    “Mechanisms of ET in improving cognitive function and preventing ARND were found to be through its antioxidative, anti-inflammatory and antisenescence properties.”

    Review

    The role of Ergothioneine in cognition and age-related neurodegenerative disease: a systematic review

    Inflammopharmacology

  4. Ergothioneine protects against neurodegenerative disease.

    “In addition to its antioxidant effect, EGT has been reported to have anti-senescence, anti-inflammatory and anti-neurodegenerative properties.”

    Review

    Ergothioneine and its prospects as an anti-ageing compound

    Experimental gerontology

More on Ergothioneine

GLP-1 receptor agonists

downin reviews4

4 studies
  1. GLP-1 receptor agonists protect against neurodegenerative disease (preclinical studies).

    “Preclinical studies consistently demonstrated neuroprotective effects of GLP-1RAs through modulation of neuroinflammation, oxidative stress, mitochondrial dysfunction, synaptic plasticity, and neuronal survival pathways.”

    Reviewpreclinical studies

    GLP-1 AND DUAL GLP-1/GIP RECEPTOR AGONISTS AS NEUROPROTECTIVE AGENTS: MECHANISMS, CLINICAL EVIDENCE, AND TRANSLATIONAL PERSPECTIVES

    International Journal of Innovative Technologies in Social Science

  2. GLP-1 receptor agonists protect against neurodegenerative disease.

    “Glucagon-like peptide-1 receptor agonists (GLP1-RAs), widely used for type 2 diabetes mellitus, are emerging as promising neuroprotective therapies in Alzheimer's disease (AD) and Parkinson's disease (PD).”

    Reviewin Alzheimer's disease and Parkinson's disease, as reviewed from preclinical and clinical studies

    GLP-1 agonists in neurodegeneration: a multimodal biomarker-guided approach

    Trends in molecular medicine

  3. GLP-1 receptor agonists protect against neurodegenerative disease in in vitro and in vivo models.

    “Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases”

    Reviewin in vitro and in vivo models

    Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease

    Journal of biomedical science

  4. GLP-1 receptor agonists protect against neurodegenerative disease.

    “beneficial effects on several other pathologies, including cardiovascular diseases, neurodegeneration, kidney disease, and cancer”

    Review

    GLP1 Receptor Agonists-Effects beyond Obesity and Diabetes

    Cells

More on GLP-1 receptor agonists

Rapamycin

downin reviews2downin flies1downin rats1

4 studies
  1. Rapamycin protects against neurodegenerative disease.

    “pharmacological inhibition of mTORC1 using rapamycin or its analogs (rapalogs) has demonstrated significant neuroprotective potential.”

    Review

    Unlocking the aging brain: mTORC1 as a convergent integrator for neurodegeneration and therapeutic intervention

    Biogerontology

  2. Rapamycin decreases neurodegenerative disease.

    “The drug rapamycin has beneficial effects in a number of animal models of neurodegeneration and aging”

    Reviewin animal models of neurodegeneration and aging, including mouse models of Alzheimer's disease

    Rapamycin and Alzheimer's disease: Time for a clinical trial?

    Science translational medicine

  3. Rapamycin decreases neurodegenerative disease in rats (aging rat brain).

    “provided significant protection to aging rat brain by reducing the aging-induced oxidative stress, apoptotic cell death, and markers of neurodegeneration”

    Animalsaging rat brainbrain0.5 mg/kg b.w.28 days

    Rapamycin Confers Neuroprotection Against Aging-Induced Oxidative Stress, Mitochondrial Dysfunction, and Neurodegeneration in Old Rats Through Activation of Autophagy

    Rejuvenation research

  4. Rapamycin protects against neurodegenerative disease in dNrd1 mutant flies.

    “Inhibition of mTOR activity by rapamycin or partially restoring autophagy delays neurodegeneration in dNrd1 mutant flies.”

    Model organismsin dNrd1 mutant fliesphotoreceptor neurons

    Loss of Nardilysin, a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and Neurodegeneration

    Neuron

More on Rapamycin

Nicotinamide riboside

downin mice3downin reviews1

4 studies
  1. Nicotinamide riboside protects against neurodegenerative disease in mice (rAAV-CMV-LacZ injection into the hippocampus).

    “We found that NR supplementation partially rescued the rAAV-induced neurodegeneration in the CA3 of the hippocampus.”

    AnimalsrAAV-CMV-LacZ injection into the hippocampusdrinking waterhippocampal CA312mM12 weeks until sacrifice

    NICOTINAMIDE RIBOSIDE SUPPLEMENTATION PROTECTS AGAINST VIRAL-INDUCED NEURODEGENERATION IN AGED MICE

    GSA 2024 abstract

  2. Nicotinamide riboside protects against neurodegenerative disease.

    “provide protective effects against a broad spectrum of pathological conditions, such as neurodegenerative diseases, diabetes, and hearing loss.”

    Review

    Emerging Role of Nicotinamide Riboside in Health and Diseases

    Nutrients

  3. Nicotinamide riboside decreases neurodegenerative disease in mice after LPS administration.

    “or nicotinamide riboside (NR), an NAD+ precursor, increased NAD+ level, and significantly suppressed induction of cytokines and chemokines, glial activation and subsequent neurodegeneration after LPS administration”

    Animalsafter LPS administration

    Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD

    Journal of neurochemistry

  4. Nicotinamide riboside decreases neurodegenerative disease in mice (Top1 cKO mice) (partial).

    “Supplementation of nicotinamide adenine dinucleotide (NAD+) with nicotinamide riboside partially blocked neurodegeneration”

    AnimalsTop1 cKO mice

    Deletion of Topoisomerase 1 in excitatory neurons causes genomic instability and early onset neurodegeneration

    Nature communications

More on Nicotinamide riboside

NAD+ precursors

downin reviews3

3 studies
  1. NAD+ precursors decrease neurodegenerative disease (early supplementation; less effective once disease is fully developed).

    “Current clinical studies suggest that early supplementation with NAD precursors may help slow the aging and neurodegeneration processes.”

    Reviewearly supplementation; less effective once disease is fully developed

    Metabolic Brain Disorders: Prodromes, Symptoms, and Syndromes

    International journal of molecular sciences

  2. NAD+ precursors protect against neurodegenerative disease.

    “protects against neurodegeneration”

    Review

    The therapeutic perspective of NAD⁺ precursors in age-related diseases

    Biochemical and biophysical research communications

  3. NAD+ precursors decrease neurodegenerative disease in preclinical studies.

    “Preclinical studies have revealed great potential for NAD+ precursors in promotion of healthy aging and improvement of neurodegeneration.”

    Reviewin preclinical studies

    Roles of NAD⁺ in Health and Aging

    Cold Spring Harbor perspectives in medicine

More on NAD+ precursors

Flavonoids

downin reviews3

3 studies
  1. Flavonoids protect against neurodegenerative disease.

    “flavonoids and curcuminoids stand out for their extensively documented antioxidant, antiplatelet, and neuroprotective properties”

    Review

    The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases

    Molecular neurobiology

  2. Flavonoids protect against neurodegenerative disease.

    “specifically emphasizing the promising role of flavonoids in mitigating NDD-related complications.”

    Review

    Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs

    Ageing research reviews

  3. Flavonoids protect against neurodegenerative disease.

    “the regulatory role of flavonoids in managing various NDDs has been shown to pass through AMPK/PGC-1α signaling pathway”

    Review

    Flavonoids modulate AMPK/PGC-1α and interconnected pathways toward potential neuroprotective activities

    Metabolic brain disease

More on Flavonoids

Ketogenic diet

downin reviews2

2 studies
  1. Ketogenic diet protects against neurodegenerative disease.

    “KD may protect against neurodegeneration”

    Review

    Ketogenic diet as a therapeutic strategy for neurodegenerative diseases: from mechanisms to translational challenges

    Translational neurodegeneration

  2. Ketogenic diet protects against neurodegenerative disease in humans and animal models.

    “KD is beneficial to neurodegenerative diseases through modulating central and peripheral metabolism, mitochondrial function, inflammation, oxidative stress, autophagy, and the gut microbiome”

    Reviewin humans and animal models

    Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases

    Aging and disease

More on Ketogenic diet

All 112

Effects

35

Cognitive function

downin humans2

2 studies
  1. Neurodegenerative disease is linked with worse cognitive function in humans (β = 1.27, p = 0.01).

    “neurodegenerative disease was strongly associated with poorer outcomes in three of the four follow-up measures (SBT: β = 1.27, p = 0.01; EQ-5D-5L: β = 1.43, p < 0.001; BI: β = -1.63, p < 0.001)”

    Humanstwelve months

    Long-Term Cognitive and Functional Outcomes Following Postoperative Delirium and Liberal Fluid Fasting in Elderly Trauma Patients: A Prospective Single-Centre Study

    Journal of clinical medicine

  2. Neurodegenerative disease impairs cognitive function in humans.

    “Specifically, our article explores the pathological processes underlying neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases, shedding light on the structural alterations and functional impairments that accompany these conditions.”

    Review

    Unraveling the complexity of human brain: Structure, function in healthy and disease states

    Ageing research reviews

Intrinsic capacity

downin humans1

1 study
  1. Neurodegenerative disease is linked with lower intrinsic capacity in humans (β = -0.587).

    “neurodegenerative diseases, including Parkinson disease and Alzheimer disease, demonstrated the strongest negative association with IC (β = -0.587, P < .01)”

    Humans

    Multiple chronic conditions link to lower intrinsic capacity

    Medicine

Linguistic processing

downin humans1

1 study
  1. Neurodegenerative disease impairs linguistic processing in humans.

    “Neurodegenerative diseases (AD, PD, MCI, PCA, PPA) broadly impair linguistic processing at all levels and modalities”

    Review

    Multimodal assessment of the impact of cognitive decline on language processing in older adults: A systematic review

    Language and Health

Sleep-wake control

downin humans1

1 study
  1. Neurodegenerative disease impairs sleep-wake control in neurodegenerative diseases.

    “several shared symptoms including difficulty falling asleep, fragmented sleep, and disrupted circadian rhythm collectively suggest their pathologies disrupt sleep-wake control.”

    Reviewin neurodegenerative diseases

    Sleep-wake control with age and neurodegenerative diseases

    Sleep medicine reviews

Neuronal excitability

upin humans1

1 study
  1. Neurodegenerative disease increases neuronal excitability in neurodegenerative diseases.

    “Hyperexcitability of implicated neurons is commonly observed prior to neurodegeneration.”

    Reviewin neurodegenerative diseases

    Sleep-wake control with age and neurodegenerative diseases

    Sleep medicine reviews

Activities of daily living

downin humans1

1 study
  1. Neurodegenerative disease is linked with worse activities of daily living in humans (β = -1.63, p < 0.001).

    “BI: β = -1.63, p < 0.001”

    Humanstwelve months

    Long-Term Cognitive and Functional Outcomes Following Postoperative Delirium and Liberal Fluid Fasting in Elderly Trauma Patients: A Prospective Single-Centre Study

    Journal of clinical medicine

TOP1-DNA covalent complexes

upin humans1

1 study
  1. Neurodegenerative disease is linked with higher TOP1-DNA covalent complexes in humans.

    “Rapid approach to DNA adduct recovery (RADAR) assays confirmed increased TOP1-DNA covalent complexes”

    Humans

    Three brain diseases share DNA damage patterns in human neurons

    Cell

More on TOP1-DNA covalent complexes

ID4-resembling sIndel process in neurons

upin humans1

1 study
  1. Neurodegenerative disease is linked with higher ID4-resembling sIndel process in neurons in humans (compared with control neurons) (22% ALS, 76% FTD, 61% AD neurons versus 2% control neurons).

    “an sIndel process affecting 22% of ALS, 76% of FTD, and 61% of AD neurons-but only 2% of control neurons”

    Humanscompared with control neuronsneuronn = 469

    Three brain diseases share DNA damage patterns in human neurons

    Cell

More on ID4-resembling sIndel process in neurons

Somatic single-nucleotide variants and insertions/deletions

upin humans1

1 study
  1. Neurodegenerative disease is linked with higher somatic single-nucleotide variants and insertions/deletions in humans (single-cell sequencing of neurons from postmortem brains compared with controls).

    “Single-cell whole-genome sequencing of 469 neurons from C9ORF72 ALS, C9ORF72 FTD, AD, and control brains revealed increased somatic single-nucleotide variants (sSNVs) and insertions/deletions (sIndels) in all three diseases.”

    Humanssingle-cell sequencing of neurons from postmortem brains compared with controlsneuronn = 469

    Three brain diseases share DNA damage patterns in human neurons

    Cell

More on Somatic single-nucleotide variants and insertions/deletions

RPS24

upin mice1

1 study
  1. Neurodegenerative disease increases RPS24 in mice (Alzheimer's disease, Parkinson's disease, and Huntington's disease).

    “Using S24-PKE-specific antibodies, we verified increased expression of this protein variant in brains with AD, PD, and HD, and in relevant mouse models.”

    AnimalsAlzheimer's disease, Parkinson's disease, and Huntington's diseasebrain

    Neuroinflammation and neurodegeneration trigger a specific splice form of ribosomal protein S24

    Brain : a journal of neurology

More on RPS24

All 35

Upstream

74

Autophagy

downin reviews5downin mice1upin reviews1

7 studies
  1. Autophagy protects against neurodegenerative disease.

    “The therapeutic restoration of autophagic function represents a promising strategy for alleviating neurodegeneration.”

    Review

    Harnessing Neuronal Autophagy: Bridging Mechanistic Breakthroughs to Therapeutic Interventions

    Aging and disease

  2. Autophagy protects against neurodegenerative disease.

    “Impairment of glial autophagy has been implicated in non-cell-autonomous neurodegeneration, leading to excitotoxicity, myelin damage, the emergence of senescence-associated secretory phenotypes, and persistent neuroinflammation.”

    Review

    The role of glia autophagy in CNS homeostasis, ageing and disease

    Geromedicine

  3. Autophagy decreases neurodegenerative disease in animal models of neurodegeneration.

    “autophagy upregulation ameliorates disease in many animal models of neurodegeneration”

    Reviewin animal models of neurodegeneration

    Autophagy, aging, and age-related neurodegeneration

    Neuron

  4. Autophagy induces neurodegenerative disease.

    “the role of autophagy dysfunction in driving neurodegenerative disease”

    Review

    Cogs in the autophagic machine-equipped to combat dementia-prone neurodegenerative diseases

    Frontiers in molecular neuroscience

  5. Autophagy protects against neurodegenerative disease in preclinical models of age-related neurodegenerative diseases.

    “preclinical models of age-related neurodegenerative diseases demonstrate pathology modulating effect of autophagy induction, implicating its potential to treat such disorders.”

    Reviewin preclinical models of age-related neurodegenerative diseases

    Fountain of youth-Targeting autophagy in aging

    Frontiers in aging neuroscience

  6. Autophagy protects against neurodegenerative disease.

    “preclinical evidence arguing for the use of autophagy modulators as suppressors of age-related pathologies such as neurodegenerative diseases”

    Review

    Autophagy in healthy aging and disease

    Nature aging

  7. Autophagy protects against neurodegenerative disease in mice (shown by genetic inhibition of autophagy).

    “Genetic in- hibition of autophagy in mice leads to a variety of ageing-related diseases including neuro- degenerative diseases”

    Reviewshown by genetic inhibition of autophagy

    Autophagy and ageing

    Nihon rinsho. Japanese journal of clinical medicine

More on Autophagy

SIRT1

downin reviews4downin mice1

5 studies
  1. SIRT1 protects against neurodegenerative disease.

    “activation of SIRT1 has been shown to have very relevant therapeutic potential against neurodegeneration”

    Review

    SIRT1 activation and its circadian clock control: a promising approach against (frailty in) neurodegenerative disorders

    Aging clinical and experimental research

  2. SIRT1 protects against neurodegenerative disease.

    “Sirtuins, specifically the nuclear SIRT1 and mitochondrial SIRT3, have been shown to have predominantly neuroprotective roles in the CNS”

    Reviewcentral nervous system

    Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System

    Frontiers in neuroscience

  3. SIRT1 protects against neurodegenerative disease.

    “The therapeutic significance of SIRT1 has been put into perspective through a comprehensive discussion about its ameliorating potential against neurodegenerative stimuli”

    Review

    SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan

    Current neuropharmacology

  4. SIRT1 protects against neurodegenerative disease in mice (Sirt1 overexpression in SCA7 mice).

    “We crossed Sirt1-overexpressing mice with SCA7 mice and noted rescue of neurodegeneration and calcium flux defects.”

    AnimalsSirt1 overexpression in SCA7 micecerebellum

    Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7

    Neuron

  5. SIRT1 protects against neurodegenerative disease in experimental autoimmune encephalomyelitis.

    “We have studied the role of SIRT1 in experimental autoimmune encephalomyelitis (EAE) and found evidence for a neuroprotective role.”

    Reviewin experimental autoimmune encephalomyelitis

    SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review

    Journal of neuroimmunology

More on SIRT1

Sirtuin signaling

downin reviews3mediatesin reviews1

4 studies
  1. Sirtuin signaling protects against neurodegenerative disease.

    “It also plays a neuroprotective role by modulating several biological pathways such as apoptosis, DNA repair, protein aggregation, and inflammatory processes associated with ageing and neurodegenerative diseases.”

    Review

    Sirtuins, a key regulator of ageing and age-related neurodegenerative diseases

    The International journal of neuroscience

  2. Sirtuin signaling decreases neurodegenerative disease.

    “Sirtuins may counteract at least six hallmarks of organismal aging: neurodegeneration”

    Review

    Sirtuins at the Service of Healthy Longevity

    Frontiers in physiology

  3. Sirtuin signaling mediates neurodegenerative disease.

    “An increase in endogenous sirtuin activity seems to mediate the protective effect that enhancing NAD+ availability confers in several models of neurodegeneration and age-related diseases.”

    Reviewprotective effect of enhancing NAD+ availability in models of neurodegeneration and age-related diseases

    Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration

    Antioxidants & redox signaling

  4. Sirtuin signaling protects against neurodegenerative disease.

    “mitochondrial sirtuin function has been implicated in the protection against age-related pathologies, including neurodegeneration, cardiopathologies, and insulin resistance.”

    Review

    Mitochondrial Sirtuins and Molecular Mechanisms of Aging

    Trends in molecular medicine

More on Sirtuin signaling

cGAS–STING signaling

upin human cells1mediatesin reviews1downin reviews1

3 studies
  1. cGAS–STING signaling mediates neurodegenerative disease.

    “underscoring its pivotal role in neurodegenerative processes and brain health”

    Review

    The cGAS-STING pathway at the crossroads of neuroimmunology: bridging innate immunity to aging and neurodegeneration

    Biomarker research

  2. cGAS–STING signaling increases neurodegenerative disease in human cells (shown by cGAS and STING inhibition in A-T brain organoids).

    “inhibits astrocyte senescence and neurodegeneration”

    Cellsshown by cGAS and STING inhibition in A-T brain organoids

    Inhibition of the cGAS-STING pathway ameliorates the premature senescence hallmarks of Ataxia-Telangiectasia brain organoids

    Aging cell

  3. cGAS–STING signaling protects against neurodegenerative disease (excessive engagement can be deleterious).

    “it generally mediates immune surveillance and is often neuroprotective”

    Reviewexcessive engagement can be deleterious

    Signaling by cGAS-STING in Neurodegeneration, Neuroinflammation, and Aging

    Trends in neurosciences

More on cGAS–STING signaling

Cellular senescence

mediatesin reviews3

3 studies
  1. Cellular senescence mediates neurodegenerative disease (secondary neurodegeneration following brain injury).

    “cellular senescence may be a potential driver for secondary neurodegeneration following brain injury.”

    Reviewsecondary neurodegeneration following brain injury

    Cellular senescence as a key contributor to secondary neurodegeneration in traumatic brain injury and stroke

    Translational neurodegeneration

  2. Cellular senescence mediates neurodegenerative disease.

    “senescent cells have emerged as unexpected mediators of neurodegenerative diseases”

    Reviewbrain

    Evidence of the Cellular Senescence Stress Response in Mitotically Active Brain Cells-Implications for Cancer and Neurodegeneration

    Life (Basel, Switzerland)

  3. Cellular senescence mediates neurodegenerative disease.

    “suggesting that these senescent cells may play an essential role in the pathological processes of neurodegenerative diseases”

    Reviewbrain

    Evidence and perspectives of cell senescence in neurodegenerative diseases

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

More on Cellular senescence

TERT

downin reviews2downin mice1

3 studies
  1. TERT protects against neurodegenerative disease in brain and postmitotic neurons.

    “evidence has accumulated on a protective role of TERT in brain and postmitotic neurons”

    Reviewin brain and postmitotic neuronsbrain

    Telomerase in Brain: The New Kid on the Block and Its Role in Neurodegenerative Diseases

    Biomedicines

  2. TERT protects against neurodegenerative disease.

    “TERT has also been confirmed to exert extra-telomeric and neuroprotective roles in neurodegenerative diseases”

    Review

    Role of Senescence and Neuroprotective Effects of Telomerase in Neurodegenerative Diseases

    Rejuvenation research

  3. TERT protects against neurodegenerative disease in mice (telomerase deficiency with short telomeres in the brain).

    “we describe a mouse model of neurodegeneration owing to presence of short telomeres in the brain as the consequence of telomerase deficiency”

    Animalstelomerase deficiency with short telomeres in the brainbrain

    Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice

    Aging

More on TERT

Ferroptosis

mediatesin reviews2

2 studies
  1. Ferroptosis mediates neurodegenerative disease.

    “ferroptosis-an iron-dependent form of cell death driven by lipid peroxidation-has emerged as a key mechanism in neurodegeneration”

    Review

    Ferroptosis: an emerging key mechanism linking aging, surgical and anesthetic exposure to postoperative cognitive dysfunction

    Frontiers in immunology

  2. Ferroptosis mediates neurodegenerative disease.

    “ferroptosis plays a key pathogenic role in many diseases such as various cancer types, neurodegenerative disease”

    Review

    Targeting ferroptosis opens new avenues for the development of novel therapeutics

    Signal transduction and targeted therapy

More on Ferroptosis

Inflammation

upin reviews1mediatesin reviews1

2 studies
  1. Inflammation increases neurodegenerative disease.

    “This chronic inflammatory milieu promotes neurodegeneration, disrupts the synaptic activity and is involved in cognitive deficit.”

    Review

    Evaluating senescence-targeted approaches in Alzheimer's Disease: What we know and what lies ahead

    Ageing research reviews

  2. Inflammation mediates neurodegenerative disease.

    “Neuroinflammation is a hallmark of many neurodegenerative diseases (NDs) and plays a fundamental role in mediating the onset and progression of disease.”

    Review

    Microglia Phenotypes in Aging and Neurodegenerative Diseases

    Cells

More on Inflammation

Microglia

downin mice1upin reviews1

2 studies
  1. microglia protects against neurodegenerative disease in chronic OxPC lesions.

    “although microglia protected the CNS from chronic neurodegeneration”

    Animalsin chronic OxPC lesionsCNS

    Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1β signaling

    Nature neuroscience

  2. microglia increases neurodegenerative disease during aging.

    “maladaptive microglia contribute to synaptic loss, white matter deterioration, and the spread of neurodegenerative pathology.”

    Reviewduring aging

    Microglia in Brain Aging and Age-Related Diseases: Friends or Foes?

    International journal of molecular sciences

Mitochondrial dysfunction

mediatesin reviews1upin reviews1

2 studies
  1. mitochondrial dysfunction mediates neurodegenerative disease.

    “Mitochondrial dysfunction occurs early on and acts causally in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD).”

    Review

    Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators

    Aging and disease

  2. mitochondrial dysfunction increases neurodegenerative disease.

    “Mitochondrial dysfunction remains a pivotal mechanism in manifold neurodegenerative diseases.”

    Review

    Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease

    Heliyon

All 74

Associations

376

Cellular senescence

upin reviews16upin humans3mixedin reviews1

20 studies
  1. Cellular senescence is associated with neurodegenerative disease.

    “Recent studies indicate that the number of senescent astrocytes in the brain directly correlates with the development of neurodegenerative diseases.”

    Reviewbrain

    Astrocyte Structure-Function Relationship in Senescence and Neurodegeneration

    Biochemistry. Biokhimiia

  2. Cellular senescence is associated with neurodegenerative disease.

    “A growing body of evidence highlights a strong association between cellular senescence and the development of neurodegenerative disorders”

    Review

    Exploring Stem Cell Based Senotherapeutic Strategies for Targeting Cellular Senescence in Brain Aging

    Stem cell reviews and reports

  3. Cellular senescence raises the risk of neurodegenerative disease.

    “Cellular senescence is a hallmark of biological aging that plays a crucial role in the development of neurodegenerative diseases.”

    Review

    Interplay Between Autophagy, Cellular Senescence, and Brain Aging: Neuroprotective Implications of Intermittent Fasting

    Cellular and molecular neurobiology

  4. Cellular senescence raises the risk of neurodegenerative disease.

    “cellular senescence, particularly in microglia, the innate immune cells of the central nervous system, has become a significant contributor to neurodegeneration”

    Review

    Microglial Senescence in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives

    ACS chemical neuroscience

  5. Cellular senescence raises the risk of neurodegenerative disease.

    “This review highlights astrocytic senescence as a key mechanism linking brain aging to neurodegeneration.”

    Review

    From Neuron-Centric to Glia-Centric: How Aging Glial Networks Drive Neurodegenerative Disease

    Journal of neurochemistry

  6. Cellular senescence raises the risk of neurodegenerative disease.

    “propose that mitochondrial dysfunction may act as a bridge between the two”

    Review

    Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease

    npj aging

  7. Cellular senescence is associated with neurodegenerative disease.

    “Many neurodegenerative disorders are closely linked to cellular senescence caused by oxidative stress, ROS generation, and DNA damage.”

    Review

    Current aspects of targeting cellular senescence for the therapy of neurodegenerative diseases

    Frontiers in aging neuroscience

  8. Cellular senescence is associated with neurodegenerative disease.

    “Cellular senescence is a critical factor in these disorders, contributing to their onset and progression”

    Reviewbrain

    Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases

    Stem cell research & therapy

  9. Cellular senescence is associated with neurodegenerative disease.

    “Neuronal senescence, characterized by a progressive decline in structural integrity and function, is a hallmark of neurodegenerative diseases.”

    Review

    Mitochondria at the crossroads: Quality control mechanisms in neuronal senescence and neurodegeneration

    Neurobiology of disease

  10. Cellular senescence raises the risk of neurodegenerative disease.

    “immune exhaustion and senescence, even if not primary causative factors, can accelerate neurodegenerative diseases.”

    Review

    Boosting peripheral immunity to fight neurodegeneration in the brain

    Trends in immunology

All 20

More on Cellular senescence

Inflammation

upin humans5upin reviews5mixedin silico1upin silico1

12 studies
  1. Inflammation raises the risk of neurodegenerative disease in humans.

    “chronic low-grade inflammation, which contributes to the pathogenesis of numerous age-related conditions, including cancer and neurodegenerative diseases (NDDs).”

    Review

    Accelerated biological aging: the role of chronic inflammation, weathering and novel therapeutic strategies

    Frontiers in aging

  2. Neurodegenerative disease is associated with inflammation in silico.

    “The results revealed consistent dysregulation of pathways related to neuronal signaling, synaptic function, mitochondrial metabolism, neuroinflammation, and proteostasis.”

    In siliconeural tissue

    Integrative Transcriptomic Profiling of Human Neural Tissues Reveals Core Molecular Signatures of Neurodegeneration

    Journal of Natural Science Research and Review

  3. Inflammation raises the risk of neurodegenerative disease in brains of individuals with Alzheimer's Disease and Parkinson's Disease.

    “Neuroinflammation triggered by amyloid proteins and protein aggregates accelerates neurodegeneration due to increased cytokines and chemokines in the brains of individuals with Alzheimer's Disease and Parkinson's Disease.”

    Reviewin brains of individuals with Alzheimer's Disease and Parkinson's Diseasebrain

    The role of miRNAs in the development of Super-Tregs as a potential therapy for neurodegenerative diseases

    Frontiers in immunology

  4. Inflammation raises the risk of neurodegenerative disease.

    “Immune dysfunction and chronic inflammation can further result in the development and progression of neurodegenerative diseases.”

    Review

    Redox-Immune Axis and Ozone Pollution: From Oxidative Stress to Thymic Involution and Neurodegeneration

    Medical sciences (Basel, Switzerland)

  5. Neurodegenerative disease is associated with inflammation in silico across AD, PD, and HD.

    “Enrichment analysis indicated convergence on immune- and inflammation-related biological processes.”

    In silicoacross AD, PD, and HDbrain

    Comparative Multi-Omics Analysis Identifies Shared Transcriptomic Signatures and Therapeutic Targets in Alzheimer's, Parkinson's, and Huntington's Diseases

    Current issues in molecular biology

  6. Inflammation raises the risk of neurodegenerative disease in humans with aging.

    “Chronic inflammation contributes to a variety of age-related diseases, such as neurodegenerative disease, cancer, infectious disease, and autoimmune diseases.”

    Reviewwith aging

    Immunosenescence: signaling pathways, diseases and therapeutic targets

    Signal transduction and targeted therapy

  7. Inflammation raises the risk of neurodegenerative disease.

    “increased oxidative stress, and neuroinflammation, all of which contribute to the progression of NDs such as Alzheimer's (AD), Parkinson's disease (PD), Huntington's disease (HD)”

    Review

    Mapping the Connection Between Circadian Rhythms, Metabolism, and Neurodegeneration: Exploring Therapeutic Strategies

    Current Alzheimer research

  8. Inflammation raises the risk of neurodegenerative disease.

    “Finally, the role of inflammaging in the most common neurodegenerative diseases, such as Alzheimer's and Parkinson's, is also discussed.”

    Review

    Role of the mtDNA Mutations and Mitophagy in Inflammaging

    International journal of molecular sciences

  9. Inflammation is associated with neurodegenerative disease in humans.

    “Genome-wide association studies (GWAS) especially in Alzheimer's disease patients and research in Parkinson's disease have implicated inflammation and the innate immune response as risk factors.”

    Review

    Beyond Host Defense: Deregulation of Drosophila Immunity and Age-Dependent Neurodegeneration

    Frontiers in immunology

  10. Inflammation raises the risk of neurodegenerative disease in humans during normal brain aging and under certain pathological conditions.

    “this crosstalk can go beyond physiological control, resulting in an unresolved inflammatory response of the CNS-resident immune cells that might initiate and propagate the progression of severe tissue damage and neurodegeneration”

    Reviewduring normal brain aging and under certain pathological conditionscentral nervous system

    Neuroimmune Connections in Aging and Neurodegenerative Diseases

    Trends in immunology

All 12

More on Inflammation

Oxidative stress and ROS signaling

upin reviews6upin humans2downin reviews1

9 studies
  1. Oxidative stress and ROS signaling is associated with neurodegenerative disease.

    “The proposed framework connects redox failure, cellular senescence, and neurodegeneration as interdependent drivers of disease progression.”

    Review

    Redox bioenergetics of neuronal senescence in Alzheimer's disease

    International review of neurobiology

  2. Oxidative stress and ROS signaling is associated with neurodegenerative disease.

    “OS is important not only in relation to aging but also due to its strong impact on neurodegenerative diseases”

    Review

    Crosstalk between Oxidative Stress and Aging in Neurodegeneration Disorders

    Cells

  3. Oxidative stress and ROS signaling raises the risk of neurodegenerative disease in humans.

    “a disturbed endogenous pro-oxidants/antioxidants balance is considered the crucial detrimental factor that makes the brain vulnerable to aging and progressive neurodegeneration.”

    Review

    Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin

    International journal of molecular sciences

  4. Oxidative stress and ROS signaling is associated with neurodegenerative disease.

    “Emerging evidence also highlights the relationship between oxidative stress and age-related pathologies, such as protein misfolding-based neurodegenerative diseases”

    Review

    Oxidative Stress in Age-Related Neurodegenerative Diseases: An Overview of Recent Tools and Findings

    Antioxidants (Basel, Switzerland)

  5. Oxidative stress and ROS signaling is associated with neurodegenerative disease.

    “Weakening or deregulation of these self-protecting defenses orchestrated by DHA is associated with normal aging but also, more worryingly, with the development of neurodegenerative diseases.”

    Reviewbrain

    DHA and Its Elaborated Modulation of Antioxidant Defenses of the Brain: Implications in Aging and AD Neurodegeneration

    Antioxidants (Basel, Switzerland)

  6. Oxidative stress and ROS signaling raises the risk of neurodegenerative disease.

    “brain injury, oxidative stress and neuroinflammation, negatively influence the onset, severity and duration of neurodegenerative diseases”

    Review

    Dietary habits, lifestyle factors and neurodegenerative diseases

    Neural regeneration research

  7. Oxidative stress and ROS signaling is associated with neurodegenerative disease in humans (mitochondrial oxidative stress).

    “we review the role of mitochondrial oxidative stress in the aging process, with a specific focus on neurodegenerative diseases”

    Reviewmitochondrial oxidative stressbrain

    Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

    Oxidative medicine and cellular longevity

  8. Neurodegenerative disease is associated with oxidative stress and ROS signaling.

    “Oxidative stress increases in the brain with aging and neurodegenerative diseases.”

    Reviewbrain

    Redox Signaling in Neurotransmission and Cognition During Aging

    Antioxidants & redox signaling

  9. Oxidative stress and ROS signaling raises the risk of neurodegenerative disease.

    “Especially in aging and neurodegenerative diseases, oxidative stress leads to aberrant cysteine oxidations that affect protein structure and function leading to neurodegeneration”

    Review

    Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases

    Proteomics. Clinical applications

More on Oxidative stress and ROS signaling

Age

upin reviews3upin humans2upin mice1

6 studies
  1. Age raises the risk of neurodegenerative disease in humans.

    “Age is the number one risk factor for developing a neurodegenerative disease (ND), such as Alzheimer's disease (AD) or Parkinson's disease (PD).”

    Review

    More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease

    Brain, behavior, and immunity

  2. Age raises the risk of neurodegenerative disease.

    “Ageing has also been described as the primary risk factor of most neurodegenerative diseases”

    Review

    The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration

    Frontiers in cell and developmental biology

  3. Age raises the risk of neurodegenerative disease.

    “Aging increases the risk for neurodegenerative disease and brain trauma”

    Review

    Modeling Neuroregeneration and Neurorepair in an Aging Context: The Power of a Teleost Model

    Frontiers in cell and developmental biology

  4. Age raises the risk of neurodegenerative disease.

    “the biggest risk factor for neurodegenerative diseases is age”

    Review

    Stem Cells of the Aging Brain

    Frontiers in aging neuroscience

  5. Age raises the risk of neurodegenerative disease in humans.

    “Ageing is the primary risk factor for most neurodegenerative diseases, including Alzheimer disease (AD) and Parkinson disease (PD).”

    Review

    Ageing as a risk factor for neurodegenerative disease

    Nature reviews. Neurology

  6. Age is associated with neurodegenerative disease in mice (very old mice compared with physiological mouse aging).

    “we find similar signs of neurodegeneration in very old mice as the consequence of physiological mouse aging”

    Animalsvery old mice compared with physiological mouse agingbrain

    Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice

    Aging

Type 2 diabetes

upin humans3upin reviews2HR 1.23

5 studies
  1. Type 2 diabetes is linked with a higher risk of neurodegenerative disease in humans (initially diagnosed with T2D vs matched controls) (HR: 1.23, 95% CI: 1.22, 1.25, p < 0.001).

    “The overall incidence of NDs was higher in the T2D group than that in the control group (HR: 1.23, 95% CI: 1.22, 1.25, p < 0.001).”

    Humansinitially diagnosed with T2D vs matched controls10 years

    Risk of Neurodegenerative Diseases in Elderly Koreans with an Initial Diagnosis of Type 2 Diabetes: A Nationwide Retrospective Cohort Study

    Journal of diabetes research

  2. Type 2 diabetes is linked with a higher risk of neurodegenerative disease in humans (compared with matched controls) (adjusted HR 1.23 (95% CI, 1.22 ~ 1.25)).

    “The adjusted HR for ND in the T2D group compared with the control group was 1.23 (95% CI, 1.22 ~ 1.25; P < 0.001).”

    Humanscompared with matched controls10-year follow-up

    Higher risk of cancer and neurodegenerative disease in elderly Koreans with type 2 diabetes

    Research SquarePreprint

  3. Type 2 diabetes raises the risk of neurodegenerative disease.

    “Through prion-like cross-seeding, IAPP interacts with Aβ, tau, α-synuclein, and PrP, linking T2D as a major risk factor for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.”

    Review

    Amylin at the crossroads of type 2 diabetes and neurodegenerative diseases

    Ageing research reviews

  4. Type 2 diabetes raises the risk of neurodegenerative disease in humans.

    “The risk of neurodegeneration was found to be increased among people with type 2 diabetes mellitus (T2DM).”

    Review

    Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders

    European journal of pharmacology

  5. Type 2 diabetes raises the risk of neurodegenerative disease.

    “increased inflammation and neurodegenerative disease risk have been associated with type 2 diabetes mellitus (T2DM)”

    Review

    Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

    Pharmacological research

More on Type 2 diabetes

Autophagy

mixedin reviews3upin reviews2

5 studies
  1. Autophagy is associated with neurodegenerative disease.

    “Autophagy dysregulation has been implicated in the pathogenesis of several neurodegenerative diseases.”

    Review

    Neurodegenerative disease and autophagy in iPSC-based models

    Neuroscience research

  2. Autophagy is associated with neurodegenerative disease.

    “Some of these non-canonical pathways have been linked to neurodegenerative diseases”

    Review

    Non-canonical autophagy in aging and age-related diseases

    Frontiers in cell and developmental biology

  3. Autophagy is associated with neurodegenerative disease (Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis).

    “Long-term changes in mitochondrial function, autophagy dysfunction, and immune activation are commonalities shared across these age-related disorders.”

    ReviewAlzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis

    Analysis of shared underlying mechanism in neurodegenerative disease

    Frontiers in aging neuroscience

  4. Autophagy is associated with neurodegenerative disease.

    “Aberrant autophagy has a key role in aging and neurodegeneration.”

    Review

    Natural Compounds and Autophagy: Allies Against Neurodegeneration

    Frontiers in cell and developmental biology

  5. Autophagy is associated with neurodegenerative disease.

    “normal functions for autophagy in astrocytes is considered to have very vital roles in the pathogenesis of aging and neurodegenerative diseases”

    Reviewastrocytes

    Astrocytes autophagy in aging and neurodegenerative disorders

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

More on Autophagy

Frailty

upin humans4OR 3.09

4 studies
  1. Frailty is linked with a higher risk of neurodegenerative disease in AMD patients (OR 3.09, 95% CI 1.58-6.07).

    “frailty was linked to neurodegenerative diseases (odds ratio [OR] 3.09 [95% CI 1.58-6.07]), neurovascular diseases (OR 3.77 [95% CI 2.16-6.60]), and mental diseases (OR 2.09 [95% CI 1.12-3.93]).”

    Humansin AMD patients

    Association between frailty and incidence of AMD among middle-aged and older people: evidence from the UK Biobank

    Frontiers in aging

  2. Frailty is linked with a higher risk of neurodegenerative disease in humans (2.74-fold (95% CI: 2.46-3.06)).

    “pre-frail and frail individuals had 1.47-fold (95% CI: 1.39-1.55) and 2.74-fold (95% CI: 2.46-3.06) increased risk, respectively”

    Humansn = 346,025

    Cognitive reserve, frailty status, and risk of neurodegenerative diseases: a prospective cohort study

    NPJ Parkinson's disease

  3. Neurodegenerative disease is associated with frailty in decedents with neurodegenerative diseases compared to cancer decedents.

    “individuals with neurodegenerative diseases had higher baseline frailty and a dominant trajectory of advanced and stable frailty”

    Humansin decedents with neurodegenerative diseases compared to cancer decedents1 year prior to death

    Mapping the Final Journey: End-Of-Life Frailty Trajectories and Cause of Death

    Journal of the American Geriatrics Society

  4. Neurodegenerative disease is associated with frailty in humans (by Frailty Index and Frailty Phenotype) (11% by Frailty Index, 14% by Frailty Phenotype).

    “frailty was identified in 11% and 14% of participants according to the FI and FP, respectively.”

    Humansby Frailty Index and Frailty Phenotypen = 150

    Frailty Prevalence in the COMPASS-ND Study of Neurodegenerative Disorders

    Canadian geriatrics journal : CGJ

Physical activity

downin humans3downin reviews1

4 studies
  1. Physical activity is associated with neurodegenerative disease in humans.

    “reduced rates of neurodegeneration”

    Reviewbrain

    The Role of Physical Activity in Determining Brain Health among Adults

    European Journal of Medical and Health Research

  2. Physical activity lowers the risk of neurodegenerative disease in humans.

    “WW pattern was inversely associated with the risks of neurodegenerative diseases and mental health conditions”

    Review

    The Association Between "Weekend Warrior" Physical Activity Pattern and Neuropsychological Outcomes: A Systematic Review

    Behavioral sciences (Basel, Switzerland)

  3. Physical activity lowers the risk of neurodegenerative disease.

    “Research from both preclinical and clinical studies repeatedly reveals associations between regular physical activity and improved cognitive function, augmented brain structural integrity, and less neurodegeneration.”

    Review

    THE IMPACT OF REGULAR PHYSICAL ACTIVITY ON DELAYING THE ONSET OF ALZHEIMER’S DISEASE: A REVIEW OF NEUROPROTECTIVE MECHANISMS

    International Journal of Innovative Technologies in Social Science

  4. Physical activity lowers the risk of neurodegenerative disease in humans.

    “Long-term physical activity not only enhances inhibitory control but also reduces the risk of age-related cognitive decline and neurodegenerative diseases.”

    Review

    Improving brain health via the central executive network

    The Journal of physiology

More on Physical activity

circadian disruption

upin reviews3upin humans1

4 studies
  1. circadian disruption raises the risk of neurodegenerative disease.

    “Circadian disruption is recognised as a significant contributor to the molecular pathogenesis of neurodegenerative illnesses”

    Review

    Circadian disruption as a driver and target in neurodegenerative diseases: from molecular mechanisms to chronotherapeutic strategies

    Metabolic brain disease

  2. circadian disruption raises the risk of neurodegenerative disease in aging.

    “age‐related disruptions in circadian rhythms not only predispose individuals to neurodegenerative diseases but also promote the rate of disease progression.”

    Reviewin aging

    Interactions Among Circadian Rhythms, Aging, and Neurodegenerative Diseases

    AAIC 2025 abstract

  3. circadian disruption raises the risk of neurodegenerative disease.

    “the role of circadian disruption in the progression of neurodegenerative diseases such as Parkinson's and Alzheimer's”

    Review

    The interplay between circadian rhythms and aging: molecular mechanisms and therapeutic strategies

    Biogerontology

  4. circadian disruption raises the risk of neurodegenerative disease.

    “circadian and sleep disturbances, which have long been considered symptoms of many neurodegenerative conditions, may actually drive pathogenesis early in the course of these diseases”

    Review

    Mechanisms linking circadian clocks, sleep, and neurodegeneration

    Science (New York, N.Y.)

Ferroptosis

upin reviews3mixedin reviews1

4 studies
  1. Ferroptosis is associated with neurodegenerative disease.

    “Ferroptosis has been implicated in the pathophysiology of stroke, traumatic brain injury, and major neurodegenerative diseases”

    Review

    Beyond oxidative stress: Ferroptosis as a novel orchestrator in neurodegenerative disorders

    Frontiers in immunology

  2. Ferroptosis is associated with neurodegenerative disease.

    “Ferroptosis, an iron-mediated lipid peroxidation-induced programmed cell death, has recently been implicated in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).”

    Reviewbrain

    Iron homeostasis and neurodegeneration in the ageing brain: Insight into ferroptosis pathways

    Ageing research reviews

  3. Ferroptosis is associated with neurodegenerative disease.

    “Recent evidence strongly suggests the involvement of ferroptosis in various neurodegenerative diseases (NDs)”

    Review

    The role of ferroptosis in neurodegenerative diseases

    Frontiers in cellular neuroscience

  4. Ferroptosis raises the risk of neurodegenerative disease.

    “Both excitotoxicity and oxytosis/ferroptosis have been demonstrated to contribute significantly to the pathophysiology of neurodegenerative diseases”

    Review

    Excitotoxicity, Oxytosis/Ferroptosis, and Neurodegeneration: Emerging Insights into Mitochondrial Mechanisms

    Aging and disease

More on Ferroptosis

Clustering coefficient

upin humans1

1 study
  1. Neurodegenerative disease is associated with clustering coefficient in humans (baseline severity predicts greater improvement after training).

    “those with more severe baseline neurodegeneration had greater improvement in segregation after training”

    Human trialbaseline severity predicts greater improvement after trainingbrain

    Increased segregation of structural brain networks underpins enhanced broad cognitive abilities of cognitive training

    Human brain mapping

More on Clustering coefficient

All 376

Trial sponsors

Funding

466 grants since 2016

National Institute on Aging$293MNational Institute of Neurological Disorders and Stroke$128MUS Department of Veterans Affairs

Latest

Magnetic Resonance Imaging

Portable brain scans agree best on larger brain structures

Portable and standard brain scans had volume-agreement scores ranging from 0.29 to 0.95, with the closest matches for larger structures.Portable and standard brain scans had volume-agreement scores ranging from 0.29 to 0.95, with the closest matches for larger structures.

Cross-sectional studyBiomarkers

See all 7,863 papers on neurodegenerative disease